ANTHONY MAN is Chief Development Officer of Basilea Pharmaceutica. Dr.
Man has an MD from the University of Nottingham and an honors degree in
biochemistry. He is a Fellow of the Royal College of Physicians.
Following hospital practice in internal medicine and medical oncology,
Dr. Man spent 15 years in the pharmaceutical industry in England, France
and Switzerland. He has been involved in successful product development,
spanning preclinical development to commercialization. He has held a
variety of both operational and managerial positions in several
companies, most recently as Head of Translational Clinical Research and
Clinical Pharmacology in the Novartis Oncology Business Unit.
Werner Henrich - Basilea Pharmaceutica
September 14, 2001